Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
Clinical trial NCT05818085 · COMPLETED
Trial details
- NCT number
- NCT05818085
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-11
- Primary completion
- 2025-01-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.